Six Austin health care startups to watch
June 15, 2012 – Austin Business Journal
Austin is a start-up town, and many of these promising companies are yielding interesting advances for the health care sector.
Austin is a startup town, and many of these promising companies are yielding interesting advances for the health care sector. Here are some of the budding companies on my watch list.
Apollo Endosurgery Inc.: It nabbed more than $50 million from investors earlier this year. It employs 35, and is developing therapeutic endoscopy devices designed to enable minimally invasive and scarless surgical procedures.
Savara Inc: This four-year-old pharmaceutical company collected another $7 million from investors in June. It’ll use the money to further develop AeroVanc, a powder inhalant used to treat pulmonary methicillinresistant staphylococcus aureus, or MRSA, an infection in cystic fibrosis patients.
Xeris Pharmaceuticals Inc.: This 7-year-old company develops injectable drugs to treat endocrine and metabolic diseases. It’s raised more than $5 million since the start of 2011 and it’s working on another $3 million round now.
MapMyFitness Inc.: It raised $9 million in June to close its Series B round. It claims more than 9 million users, each using the app to track and share exercise plans. It moved from Denver to Austin in 2010.
Nexersys Corp.: Formed in 2009, this company just went Hollywood after its high-tech fitness machine was featured on shows such as “NCIS: Los Angeles” and DIY Network’s “Man Caves.” It, too, is seeking capital to expand.
LDR Holding Corp.: Started in 2000 and employing 200, this Austin-based company received in May another $9.7 million. In April, it received FDA clearance to market a new spinal implant product called ROI-C Lordotic Cervical Cage.
For more on the subject, be sure to catch the Austin Business Journal’s 2012 Health Care Guide, which will be published in the June 22 issue. And if you’re interested in venture capital and startups, check out the new list of Austin companies that have received the most funding in the past year. It’s on page 22 of this week’s issue.